These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 13083008)
1. The clinical value of polyvinylpyrrolidone (P.V.P.). PAMUK O; TOVELL RM Conn State Med J; 1953 Sep; 17(9):773-4. PubMed ID: 13083008 [No Abstract] [Full Text] [Related]
2. The use of polyvinylpyrrolidone iodine in eczematoid ringworm. CORNBLEET T; BARSKY S; FIRESTEIN B AMA Arch Derm; 1958 Mar; 77(3):335-6. PubMed ID: 13507717 [No Abstract] [Full Text] [Related]
7. The use of polyvinylpyrrolidone in the management of shock-like states; report of a case. O'CONNEL CL; GREENLEE DP; HERRON FT Pa Med J; 1953 Sep; 56(9):813-4. PubMed ID: 13088238 [No Abstract] [Full Text] [Related]
8. The use of polyvinylpyrrolidone as a plasma volume expander in preventing or combating shock. SINGLETON AO Tex Rep Biol Med; 1953; 11(1):138-43. PubMed ID: 13038721 [No Abstract] [Full Text] [Related]
9. A comparison of dextran, polyvinylpyrrolidone, and isotonic saline infusion in the human. ARMSTRONG JB; DOWNEY JA; FERGUSON MH; WILLIAMS HR Can J Biochem Physiol; 1954 Nov; 32(6):636-43. PubMed ID: 13209402 [No Abstract] [Full Text] [Related]
10. [Incorporation of physiologically-active substances into a colloidal blood plasma substitute. I. Incorporation of mescaline peptide into polyvinylpyrrolidone]. JATZKEWITZ H Hoppe Seylers Z Physiol Chem; 1954; 297(3-6):149-56. PubMed ID: 13221275 [No Abstract] [Full Text] [Related]
11. [Clinical observations on periston N]. BERGHOFER F Medizinische; 1953 Aug; 33-34():1061-2. PubMed ID: 13086281 [No Abstract] [Full Text] [Related]
13. [Therapeutic use of periston and periston N]. KAETHER H; WIGGER A Dtsch Med Wochenschr; 1952 Aug; 77(31-32):956-8. PubMed ID: 12979706 [No Abstract] [Full Text] [Related]
14. Clinical experience with plasma augmenters, dextran and PVP. WEIL PG; WEBSTER DR Surg Forum; 1953 Oct; 4():712-4. PubMed ID: 13187371 [No Abstract] [Full Text] [Related]
15. [Clinical contribution to periston-N therapy of tetanus]. MUHLBAUER H Munch Med Wochenschr; 1952 Dec; 94(49):2486-7. PubMed ID: 13025428 [No Abstract] [Full Text] [Related]
16. Physiological and pathological effects of long-term polyvinylpyrrolidone retention. ALTEMEIER WA; SCHIFF L; GALLE A; GIUSEFFI J; FREIMAN D; MINDRUM G; BRAUNSTEIN H AMA Arch Surg; 1954 Sep; 69(3):308-14. PubMed ID: 13188506 [No Abstract] [Full Text] [Related]
17. [Clinical effects of prolonged sympathicolysis]. SCHULTEN K; STUTTGEN G Med Klin; 1954 Dec; 49(51):2034-9. PubMed ID: 13235233 [No Abstract] [Full Text] [Related]
18. [Subtosan therapy of shock]. DE MARCHI A; BRONNIMANN R Ther Umsch; 1952 Jun; 9(3):34-8. PubMed ID: 12995333 [No Abstract] [Full Text] [Related]
19. [Treatment of icterus gravis with polyvinylpyrrolidone (periston N)]. SCHMIDT H Z Kinderheilkd; 1959; 82(1):30-9. PubMed ID: 13648586 [No Abstract] [Full Text] [Related]
20. [Use of polyvinylpyrrolidone (PVP) as a vehicle in general anesthesia by intravenous route]. ARNEDO GUTIERREZ JA; POLLEDO C Dia Med; 1956 Aug; 28(62):1905; passim. PubMed ID: 13414530 [No Abstract] [Full Text] [Related] [Next] [New Search]